Trial Details

UNKNOWN
Basic Information
Clinical ID c3047
Identifier NCT02603185
Trial Title PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease
Interventions DRUG: Hemay007|DRUG: placebo
Participant Information
Sponsor Hemay Pharmaceutical PTY. LTD.
City South Australia
Country/Region Australia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2017-01-09
Primary Completion Date 2018-03
Completion Date 2018-03